EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Marine Algae and Deriving Biomolecules for the Management of Inflammatory Bowel Diseases: Potential Clinical Therapeutics to Decrease Gut Inflammatory and Oxidative Stress Markers?

Alberto Repici, Ahmed Hasan, Anna Paola Capra iD, Sarah Adriana Scuderi iD, Irene Paterniti, Michela Campolo, Alessio Ardizzone iD, Emanuela Esposito iD

Marine Drugs · 25.07.2024 · 22 (8) · 336

DOI: 10.3390/md22080336 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Marine Drugs, online erschienen am 25.07.2024. Verfasst von Alberto Repici und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres, 31, 98166 …. Hauptthemen laut MEDLINE: Oxidative Stress, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The term “inflammatory bowel disease” (IBD) describes a class of relapse-remitting conditions that affect the gastrointestinal (GI) tract. Among these, Crohn’s disease (CD) and ulcerative colitis (UC) are two of the most globally prevalent and debilitating conditions. Several articles have brought attention to the significant role that inflammation and oxidative stress cooperatively play in the development of IBD, offering a different viewpoint both on its etiopathogenesis and on strategies for the effective treatment of these conditions. Marine ecosystems may be a significant source of physiologically active substances, supporting the search for new potential clinical therapeutics. Based on this evidence, this review aims to comprehensively evaluate the activity of marine algae and deriving biomolecules in decreasing pathological features of CD and UC. To match this purpose, a deep search of the literature on PubMed (MEDLINE) and Google Scholar was performed to highlight primary biological mechanisms, the modulation of inflammatory and oxidative stress biochemical parameters, and potential clinical benefits deriving from marine species. From our findings, both macroalgae and microalgae have shown potential as therapeutic solutions for IBD due to their bioactive compounds and their anti-inflammatory and antioxidant activities which are capable of modulating markers such as cytokines, the NF-κB pathway, reactive oxidative and nitrosative species (ROS and RNS), trefoil factor 3 (TFF3), lactoferrin, SIRT1, etc. However, while we found promising preclinical evidence, more extensive and long-term clinical studies are necessary to establish the efficacy and safety of marine algae for IBD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressInflammatory Bowel DiseasesHumansAnimalsAnti-Inflammatory AgentsBiomarkersSeaweedMicroalgaeAntioxidantsAquatic OrganismsInflammation

Stichwörter der Autor:innen

inflammationinflammatory bowel disease (IBD)marine algaeoxidative stress

Substanzen

Anti-Inflammatory AgentsBiomarkersAntioxidants

Autor:innen und Institutionen

  • Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres, 31, 98166 Messina, Italy.
  • School of Advanced Studies, Center of Neuroscience, University of Camerino, 62032 Camerino, Italy.

ORCID-Profile: Anna Paola Capra, Sarah Adriana Scuderi, Alessio Ardizzone, Emanuela Esposito

Zitieren

APA

Repici, A., Hasan, A., Capra, A. P., Scuderi, S. A., Paterniti, I., Campolo, M., Ardizzone, A., & Esposito, E. (2024). Marine Algae and Deriving Biomolecules for the Management of Inflammatory Bowel Diseases: Potential Clinical Therapeutics to Decrease Gut Inflammatory and Oxidative Stress Markers?. Marine Drugs, 22(8), 336. https://doi.org/10.3390/md22080336

Vancouver

Repici A, Hasan A, Capra AP, Scuderi SA, Paterniti I, Campolo M, et al. Marine Algae and Deriving Biomolecules for the Management of Inflammatory Bowel Diseases: Potential Clinical Therapeutics to Decrease Gut Inflammatory and Oxidative Stress Markers?. Marine Drugs. 2024;22(8):336. doi:10.3390/md22080336

BibTeX
@article{Repici2024,
  author = {Repici, Alberto and Hasan, Ahmed and Capra, Anna Paola and Scuderi, Sarah Adriana and Paterniti, Irene and Campolo, Michela and Ardizzone, Alessio and Esposito, Emanuela},
  title = {Marine Algae and Deriving Biomolecules for the Management of Inflammatory Bowel Diseases: Potential Clinical Therapeutics to Decrease Gut Inflammatory and Oxidative Stress Markers?},
  journal = {Marine Drugs},
  year = {2024},
  volume = {22},
  number = {8},
  pages = {336},
  doi = {10.3390/md22080336}
}
Kostenlos starten →